Hadi, Najah R <br/><br/>
Role of NF-κβ and oxidative pathways in atherosclerosis: cross-talk between dyslipidemia and candesartan.  [electronic resource] 

 -  Cardiovascular therapeutics  Dec 2013 
 - 381-7 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1755-5922 
<br/><br/><label>Standard No.: </label>10.1111/1755-5922.12033  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiotensin II Type 1 Receptor Blockers--therapeutic use<br/>Animals<br/>Atherosclerosis--drug therapy<br/>Benzimidazoles--pharmacology<br/>Biphenyl Compounds<br/>Cell Movement--drug effects<br/>Chemokines--analysis<br/>Cytokines--analysis<br/>Dyslipidemias--drug therapy<br/>Lipids--blood<br/>Monocytes--drug effects<br/>NF-kappa B--physiology<br/>Oxidation-Reduction<br/>Rabbits<br/>Tetrazoles--pharmacology<br/>Vascular Cell Adhesion Molecule-1--analysis